3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
44
Liver Neoplasms
18
Colorectal Neoplasms
15
Neoplasm Metastasis
11
Cholangiocarcinoma
11
Pancreatic Neoplasms
9
Colonic Neoplasms
9
Barrett Esophagus
7
Rectal Neoplasms
6
Recurrence
5
Esophageal Neoplasms
4
Biliary Tract Neoplasms
3
Bile Duct Neoplasms
3
Hepatitis B
2
Gallbladder Neoplasms
2
Stomach Neoplasms
1
Solid Tumor Including Thyroid, Bone, Liver, Pancreas
1
Pancreatic cancer, adult
1
Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Neoplasm Micrometastasis
1
Multi-organ Metastatic Colorectal Cancer
1
Liver Metastasis Colon Cancer
1
Klatskin Tumor
1
Jaundice, Obstructive
1
Hypertension, Portal
1
Hepatitis B, Chronic
1
Interventions
Oxaliplatin
295
Capecitabine
209
Fluorouracil
183
Cisplatin
172
Docetaxel
140
S 1 (combination)
135
Paclitaxel
128
Leucovorin
117
Irinotecan
110
pembrolizumab
104
Trastuzumab
76
Nivolumab
59
apatinib
57
Drug Therapy
52
sintilimab
46
Surgical Procedures, Operative
45
Ramucirumab
40
Radiotherapy
40
Bevacizumab
37
Hyperthermic Intraperitoneal Chemotherapy
34
Epirubicin
32
titanium silicide
31
tislelizumab
31
Carboplatin
31
Gastrectomy
28
Cyclophosphamide
27
XELOX
25
Tegafur
24
Folfox protocol
23
Albumin-Bound Paclitaxel
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Radiofrequency Ablation
×
Gastrointestinal
×
Clear all
NCT04574245
2022-10-05
RECORD
Chinese PLA General Hospital
Unknown
3,000 enrolled